Mont L, Cinca J, Blanch P, Blanco J, Figueras J, Brotons C, Soler-Soler J
Servicio de Cardiología, Hospital General Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
J Am Coll Cardiol. 1996 Dec;28(7):1670-6. doi: 10.1016/S0735-1097(96)00383-X.
The purpose of the study was to analyze the factors that favor the occurrence of sustained monomorphic ventricular tachycardia in the early phase (< 48 h) of acute myocardial infarction and to establish its prognostic implications.
Sustained monomorphic ventricular tachycardia early in the course of an acute myocardial infarction is an uncommon arrhythmia, and its significance has not been specifically studied.
The clinical characteristics and prognosis of sustained monomorphic ventricular tachycardia were studied in 21 (1.9%) of 1,120 consecutive patients admitted to the coronary care unit with a diagnosis of myocardial infarction.
Patients with sustained monomorphic ventricular tachycardia had a larger infarct on the basis of peak creatine kinase, MB fraction (CK-MB) isoenzyme activity (435 +/- 253 IU/liter vs. 168 +/- 145 IU/liter, p < 0.001) and higher mortality rate (43% vs. 11%, p < 0.001). By logistic regression analysis, independent predictors of sustained monomorphic ventricular tachycardia were CK-MB (odds ratio [OR] 11.8), Killip class (OR 4.0) and bifascicular bundle branch block (OR 3.1). Moreover, sustained monomorphic ventricular tachycardia was itself an independent predictor of mortality (OR 5.0). Compared with patients with ventricular fibrillation, those with sustained monomorphic ventricular tachycardia had a worse Killip class (Killip class > I: 63% vs. 30%, p < 0.05), higher CK-MB activity (430 +/- 260 IU/liter vs. 242 +/- 176 IU/liter, p < 0.01) and higher arrhythmia recurrence rate (31% vs. 4%, p < 0.01). During the follow-up period, 5 (42%) of 12 survivors in the sustained monomorphic ventricular tachycardia group died of cardiac-related causes. Recurrence of ventricular tachycardia was seen in two patients (17%).
Sustained monomorphic ventricular tachycardia during the first 48 h of myocardial infarction is a sign of extensive myocardial damage and an independent predictor of in-hospital mortality.
本研究旨在分析急性心肌梗死早期(<48小时)发生持续性单形性室性心动过速的相关因素,并确定其预后意义。
急性心肌梗死病程早期出现的持续性单形性室性心动过速是一种罕见的心律失常,其意义尚未得到专门研究。
对1120例连续入住冠心病监护病房且诊断为心肌梗死的患者中的21例(1.9%)持续性单形性室性心动过速患者的临床特征及预后进行研究。
持续性单形性室性心动过速患者基于肌酸激酶峰值、肌酸激酶同工酶MB活性(435±253IU/L对168±145IU/L,p<0.001)梗死面积更大,死亡率更高(43%对11%,p<0.001)。通过逻辑回归分析,持续性单形性室性心动过速的独立预测因素为肌酸激酶同工酶MB(比值比[OR]11.8)、Killip分级(OR 4.0)和双分支束支传导阻滞(OR 3.1)。此外,持续性单形性室性心动过速本身就是死亡率的独立预测因素(OR 5.0)。与室颤患者相比,持续性单形性室性心动过速患者Killip分级更差(Killip分级>I:63%对30%,p<0.05),肌酸激酶同工酶MB活性更高(430±260IU/L对242±176IU/L,p<0.01),心律失常复发率更高(31%对4%,p<0.01)。随访期间,持续性单形性室性心动过速组12例幸存者中有5例(42%)死于心脏相关原因。两名患者(17%)出现室性心动过速复发。
心肌梗死发病48小时内出现的持续性单形性室性心动过速是广泛心肌损伤的标志,是院内死亡的独立预测因素。